Biopolymers in Stimuli-triggered and Enzymeactivated Drug Delivery Systems

Biopolymers have emerged as a crucial component in advanced drug delivery systems due to their low toxicity, biodegradability, and inherent biocompatibility. Their ability to respond to specific stimuli or enzymes offers enhanced control over the release of therapeutic agents, making them highly valuable in precision medicine. Stimuli-triggered systems utilize external or internal signals such as pH, magnetic fields, temperature, redox potential, and light to precisely control drug release at targeted sites. For example, pH-sensitive biopolymers can release drugs in the acidic environment of tumors, while temperature-responsive systems adapt to local heat variations in tissues. This method ensures efficient drug delivery while minimizing side effects by targeting specific diseased areas. Enzyme-activated systems, on the other hand, rely on the presence of specific enzymes in the body to trigger the degradation of biopolymers and release the encapsulated drugs. These systems are beneficial in diseases such as cancer or infections, where overexpressed enzymes can be exploited for localized drug delivery. Biopolymers such as chitosan, dextran, alginate, and hyaluronic acid have been widely used in these enzyme-responsive systems, showing promising results in selective drug release. The precision and adaptability of biopolymer-based systems provide numerous benefits, including reduced systemic toxicity, controlled drug release, and enhanced therapeutic efficacy. However, challenges such as ensuring the stability of biopolymers in physiological conditions and scaling up production remain key obstacles. Ongoing research into novel biopolymers and more specific response mechanisms continues to push the boundaries of personalized medicine. Overall, biopolymer-based delivery systems signify a cutting-edge approach to achieving precise and controlled therapeutic interventions.